Please login to the form below

Not currently logged in
Email:
Password:

Villaris Therapeutics

This page shows the latest Villaris Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Incyte to acquire Villaris Therapeutics to expand inflammation and autoimmunity portfolio

Incyte to acquire Villaris Therapeutics to expand inflammation and autoimmunity portfolio

Incyte and Villaris Therapeutics (Villaris) – an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development of novel antibody therapeutics for vitiligo – have entered into an agreement, under which ... Incyte will

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...